
Dec 24 (Reuters) - ImmuCell Corp ICCC.O:
EXPECTS NON-CASH IMPAIRMENT WRITE-DOWN FOR RE-TAIN DURING Q4 (REMOVES EXTRANEOUS WORD '$15.5 MILLION')
IMMUCELL ANNOUNCES STRATEGIC FOCUS ON FIRST DEFENSE® AFTER RECEIVING AN FDA INCOMPLETE LETTER FOR RE-TAIN®
PAUSES INVESTMENT IN RE-TAIN